Literature DB >> 3626948

Eosinophilic meningoencephalitis with permanent sequelae.

P Prociv, J R Tiernan.   

Abstract

The youngest patient with eosinophilic meningoencephalitis to be reported from Australia, an 11-month-old girl, is presented here. The diagnosis of angiostrongyliasis was based on the exclusion of other possibilities, the strongly-positive results of serological examination and the findings of an environmental survey. Clinical signs of serious brain damage, with persistent blindness, profound mental retardation, spasticity and epilepsy more than three years later, indicate that this infection is not always as benign as is considered generally.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3626948

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  5 in total

1.  Eosinophilic meningitis due to Angiostrongylus cantonensis.

Authors:  A J Fuller; W Munckhof; L Kiers; P Ebeling; M J Richards
Journal:  West J Med       Date:  1993-07

Review 2.  Twenty two cases of canine neural angiostrongylosis in eastern Australia (2002-2005) and a review of the literature

Authors:  Julian A Lunn; Rogan Lee; Joanna Smaller; Bruce M MacKay; Terry King; Geraldine B Hunt; Patricia Martin; Mark B Krockenberger; Derek Spielman; Richard Malik
Journal:  Parasit Vectors       Date:  2012-04-05       Impact factor: 3.876

3.  Case Report: Angiostrongylus cantonensis Infection Presenting as Small Fiber Neuropathy.

Authors:  Johnnie Yates; Todd Devere; Sharin Sakurai-Burton; Brock Santi; Cali McAllister; Kiana Frank
Journal:  Am J Trop Med Hyg       Date:  2022-07-05       Impact factor: 3.707

4.  Eosinophilic Meningitis.

Authors:  Trevor Slom; Stuart Johnson
Journal:  Curr Infect Dis Rep       Date:  2003-08       Impact factor: 3.725

Review 5.  Species of Angiostrongylus (Nematoda: Metastrongyloidea) in wildlife: A review.

Authors:  David M Spratt
Journal:  Int J Parasitol Parasites Wildl       Date:  2015-03-09       Impact factor: 2.674

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.